Differentiation of Leishmania (Viannia) panamensis and Leishmania (V.) guyanensis using BccI for hsp70 PCR-RFLP

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 104, Issue 5, 2010, Pages 364-367

  Montalvo Alvarez, Ana Margarita ^a   Nodarse, Jorge Fraga ^a   Goodridge, Ivón Montano ^a   Fidalgo, Lianet Monzote ^a   Marin, Marcel ^b   Van Der Auwera, Gert ^c   Dujardin, Jean Claude ^c   Bernal, Iván Darío Velez ^b   Muskus, Carlos ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Cuba; Hsp70; Leishmania; Leishmaniasis; PCR; Restriction Fragment Length Polymorphism

Indexed keywords

HEAT SHOCK PROTEIN 70;

AGAR GEL ELECTROPHORESIS; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENETIC CODE; GENETIC SIMILARITY; GENOTYPE; LEISHMANIA; LEISHMANIA PANAMENSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE IDENTIFICATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES DIFFERENCE; SPECIES IDENTIFICATION;

HSP70 HEAT-SHOCK PROTEINS; HUMANS; LEISHMANIA GUYANENSIS; LEISHMANIASIS, CUTANEOUS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY;

LEISHMANIA GUYANENSIS; LEISHMANIA PANAMENSIS; VIANNIA;

EID: 77952957850     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2009.12.002     Document Type: Article

References (22)

1. Calvopina M., Gómez E.A., Uezato H., Kato H., Nonaka S., Hashigushi Y. Atypical clinical variants in New World cutaneous leishmaniasis: disseminated, erypseloid, and recidiva cutis due to Leishmania (V.) panamensis. Am J Trop Med Hyg 2005, 73:281-284.
2. Reithinger R., Dujardin J.C. Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol 2007, 45:21-25.
3. Rotureau B., Ravel C., Couppié P., Pratlong F., Nacher M., Dedet J.P., et al. Use of PCR-restriction fragment length polymorphism analysis to identify the main New World Leishmania species and analyze their taxonomic properties and polymorphism by application of the assay to clinical samples. J Clin Microbiol 2006, 44:459-467.
4. Alvar J., Croft S., Olliaro P. Chemotherapy in the treatment and control of lesihmaniasis. Adv Parasitol 2006, 61:227-279.
5. Arévalo J., Ramirez L., Adaui V., Zimic M., Tulliano G., Miranda-Verástegui C., et al. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J Infect Dis 2007, 195:1846-1851.
6. Bañuls A.L., Jonquieres R., Guerrini F., Le Pont F., Barrera C., Espinel I., et al. Genetic analysis of Leishmania parasites in Ecuador: are Leishmania (Viannia) panamensis and Leishmania (V.) guyanensis distinct taxa?. Am J Trop Med Hyg 1999, 61:838-845.
7. WHO. Control of the leishmaniases. Report of a WHO Expert Committee. Geneva: World Health Organization; 1990. Technical Report Series No. 793.
8. Saravia N.G., Holguin A.F., McMahon-Pratt D., D'Alessandro A. Mucocutaneous leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity. Am J Trop Med Hyg 1985, 34:714-720.
9. Osorio L.E., Castillo C.M., Ochoa M.T. Mucosal leishmaniasis due to Leishmania (Vianna) panamensis in Colombia: clinical characteristics. Am J Trop Med Hyg 1998, 59:49-52.
10. Santrich C., Segura I., Arias A.L., Saravia N.G. Mucosal disease caused by Leishmania braziliensis guyanensis. Am J Trop Med Hyg 1990, 42:51-55.
11. Marsden P.D. Mucosal leishmaniasis (" espundia" Escomel, 1911). Trans R Soc Trop Med Hyg 1986, 80:859-876.
12. Lainson R., Shaw J.J. Evolution, classification and geographical distribution. The leishmaniases in biology and medicine 1987, 1-120. Academic Press, London. W. Peters, R. Killick-Kendrick (Eds.).
13. Killick- Kendrick R. Phlebotomine vectors of the Leishmaniasis: a review. Med Vet Entomol 1990, 4:1-24.
14. Romero G.A.S., de Farias- Guerra M.C., Gomes-Paes M., de Oliveira- Macedo V. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: clinical findings and diagnostic approach. Clin Infect Dis 2001, 32:1304-1312.
15. Corredor A., Kreutzer R.D., Tesh R.B., Boshell J., Palau M.T., Caceres E., et al. Distribution and ecology of leishmaniasis in Colombia. Am J Trop Med Hyg 1990, 42:206-214.
16. Lucas C.M., Franke E.D., Cachay M.I., Tejada A., Cruz M.E., Kreutzer R.D., et al. Geographic distribution and clinical description of leishmaniasis cases in Peru. Am J Trop Med Hyg 1998, 59:312-317.
17. Christensen H.A., de Vasquez A.M., Petersen J.L. Short Report: Epidemiologic studies on cutaneous leishmaniasis in Eastern Panama. Am J Trop Med Hyg 1999, 60:54-57.
18. García L., Kindt A., Bermudez H., Llanos-Cuentas A., De Doncker S., Arévalo J., et al. Culture independent species typing of neotropical Leishmania for clinical validation of a PCR-based assay targeting heat shock protein 70 genes. J Clin Microbiol 2004, 42:2294-2297.
19. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning. a laboratory manual 1989, Cold Spring Harbor: Cold Spring Harbor Laboratory. 2nd ed.
20. Saravia N.G., Weigle K., Navas C., Segura I., Valderrama L., Valencia A.Z., et al. Heterogeneity, geographic distributions and pathogenicity of serodemes of Leishmania Viannia in Colombia. Am J Trop Med Hyg 2002, 66:738-744.
21. Rodríguez-Barraquer I., Góngora R., Prager M., Pacheco R., Montero L.M., Nevas A., Ferro C., Miranda M.C., Saravia N.G. Ethiological agent of an epidemic of cutaneous leishmaniasis in Tolima. Colombia. Am J Trop Med Hyg 2008, 78:276-282.
22. Pérez J.E., Veland N., Espinosa D., Torres K., Ogusuku E., Llanos-Cuentas A., et al. Isolation and molecular identification of Leishmania (Viannia) peruviana from naturally infected Lutzomyia peruensis (Diptera: Psychodidae) in the Peruvian Andes. Mem Inst Oswaldo Cruz 2007, 102:655-658.